Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00220_DB00361> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00220_DB00361 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00220_DB00361 label "DDI between Nelfinavir and Vinorelbine - Nelfinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of Vinorelbine by decreasing its metabolism. Consider alternate therapy to avoid Vinorelbine toxicity. Monitor for changes in the therapeutic and adverse effects of Vinorelbine if Nelfinavir is initiated, discontinued or dose changed. [drugbank_resource:DB00220_DB00361]" assertion.
- drugbank_resource:DB00220_DB00361 identifier "drugbank_resource:DB00220_DB00361" assertion.
- drugbank_resource:DB00220_DB00361 title "DDI between Nelfinavir and Vinorelbine - Nelfinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of Vinorelbine by decreasing its metabolism. Consider alternate therapy to avoid Vinorelbine toxicity. Monitor for changes in the therapeutic and adverse effects of Vinorelbine if Nelfinavir is initiated, discontinued or dose changed." assertion.